Wedbush Securities’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-526
| Closed | -$67K | – | 1006 |
|
|
2019
Q4 | $67K | Buy |
526
+100
| +23% | +$12.7K | 0.01% | 950 |
|
|
2019
Q3 | $48K | Buy |
426
+34
| +9% | +$3.83K | ﹤0.01% | 942 |
|
|
2019
Q2 | $54K | Buy |
+392
| New | +$54K | 0.01% | 944 |
|
|
2018
Q3 | – | Sell |
-15
| Closed | -$32K | – | 943 |
|
|
2018
Q2 | $32K | Hold |
15
| – | – | ﹤0.01% | 852 |
|
|
2018
Q1 | $42K | Buy |
15
+6
| +67% | +$16.8K | 0.01% | 789 |
|
|
2017
Q4 | $39K | Buy |
9
+3
| +50% | +$13K | ﹤0.01% | 827 |
|
|
2017
Q3 | $46K | Sell |
6
-1
| -14% | -$7.67K | 0.01% | 808 |
|
|
2017
Q2 | $35K | Buy |
7
+1
| +17% | +$5K | ﹤0.01% | 812 |
|
|
2017
Q1 | $31K | Buy |
6
+5
| +500% | +$25.8K | ﹤0.01% | 820 |
|
|
2016
Q4 | $8K | Sell |
1
-2
| -67% | -$16K | ﹤0.01% | 814 |
|
|
2016
Q3 | $38K | Hold |
3
| – | – | 0.01% | 801 |
|
|
2016
Q2 | $40K | Hold |
3
| – | – | 0.01% | 742 |
|
|
2016
Q1 | $52K | Hold |
3
| – | – | 0.01% | 698 |
|
|
2015
Q4 | $50K | Hold |
3
| – | – | 0.01% | 682 |
|
|
2015
Q3 | $50K | Buy |
3
+2
| +200% | +$33.3K | 0.01% | 664 |
|
|
2015
Q2 | $34K | Hold |
1
| – | – | 0.01% | 701 |
|
|
2015
Q1 | $26K | Hold |
1
| – | – | ﹤0.01% | 717 |
|
|
2014
Q4 | $18K | Buy |
+1
| New | +$18K | ﹤0.01% | 701 |
|